Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Joe Biden and Donald Trump Tied in Approval Ratings

inews24 Views  

A poll on the 4th and 5th shows a tie for approval rating at 45%
“Defense industry is positive despite Trump’s comments on increase of defense cost sharing with Korea.”

Anticipations are high as President Joe Biden will possibly have a rematch with former President Donald Trump in the upcoming November presidential election, four years after their last face-off. Domestic investors have started looking for beneficial stocks related to the strong candidates.

[Photo=Newsis]

On the 12th, the securities industry recommended paying attention to growth stocks, defense, traditional energy sectors, and biotech companies, which have historically benefited from Trump’s candidacy. On the other hand, if President Biden is in the lead, the benefited businesses would be green energy, healthcare services, and infrastructure industries.

President Biden, who has been trailing Trump in every approval rating survey since last October, tied with Donald Trump after “Super Tuesday” on the 4th. In a poll conducted on the 4th and 5th by Emerson College with 1,350 voters, both candidates recorded a 45% approval rating.

In response to the clear final candidates, Choi Bo-won, a researcher at Korea Investment & Securities, said, “The easing of uncertainties about the primary elections to be held until June is positive,” and added, “Since the outlines of the final candidates are emerging faster than usual, the timing of the policy concretization by the candidates may be brought forward ahead of the party conventions of the two parties to be held this summer.”

The benefited businesses from each candidate within the U.S. are similar to the securities market’s expectations. If the Republican Party and Trump’s approval ratings are high, defense companies are expected to benefit. Researcher Choi advised, “We need to be aware that if Trump’s approval rating is high, diplomatic uncertainty can increase,” and added, “In addition to defense, which benefits from geopolitical risks, we should also pay attention to essential consumer goods companies that are less affected by diplomatic uncertainty.”

Researcher Choi continued, “Green energy companies are typical businesses that will fluctuate significantly depending on Biden’s approval rating,” and added, “Within healthcare, as the impact of Obamacare is reflected, we should also pay attention to the healthcare policy beneficiary businesses.”

However, there are opinions that it is difficult to determine the beneficiary stocks of each candidate by comparing them to the previous elections. Trump has previously stated that he will “significantly increase defense cost sharing with Korea and Japan,” which could negatively affect the stock prices of domestic defense companies.

Yet, Jo Yeon-ju, a researcher at H Investment & Securities, said, “Despite this, Trump’s remarks could lead to increased interest in K-defense,” and added, “If Trump is re-elected and defense spending increases worldwide, interest in K-defense could increase even more.”

inews24
content@viewusglobal.com

Comments0

300

Comments0

[WORLD] Latest Stories

  • Porsche Taycan GTS Breaks Guinness Record with 10.9-Mile Ice Drift
  • Africa's MPOX Variant Clade 1b Reaches France: Health Officials Take Action
  • LA Wildfires’ Economic Toll Hits $50 Billion, Doubling Early Estimates
  • Real Reason Trump Wants Greenland and the Panama Canal: Geopolitical Dominance
  • Biden Targets China, Russia with New Semiconductor Export Limits
  • Wildfire Chaos in California: 150,000 Evacuated as Flames Spread

You May Also Like

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE&nbsp

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE&nbsp

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE&nbsp

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE&nbsp

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE&nbsp

Must-Reads

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE 

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE